A new clinical study suggests that narrow Band Ultraviolet B (NB-UVB) phototherapy is effective, well-tolerated treatment for ...
By Lori Solomon HealthDay ReporterTHURSDAY, Oct. 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
Johnson & Johnson has announced that the US Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for use in ...